MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence

Description

MoVE Trial is a randomized clinical trial designed to rigorously test the impact of a behavioral intervention (culturally tailored motivational interviewing - (MOVE)) delivered by trained health coaches, on hemodialysis treatment non-adherence. It is a a two-arm, parallel group randomized clinical trial with 24-week follow-up. It involves completion of surveys by patients enrolled in the study. It also involves participation in motivational interviewing sessions by patients who are randomized to the intervention (MI).

Conditions

End Stage Renal Disease on Dialysis

Study Overview

Study Details

Study overview

MoVE Trial is a randomized clinical trial designed to rigorously test the impact of a behavioral intervention (culturally tailored motivational interviewing - (MOVE)) delivered by trained health coaches, on hemodialysis treatment non-adherence. It is a a two-arm, parallel group randomized clinical trial with 24-week follow-up. It involves completion of surveys by patients enrolled in the study. It also involves participation in motivational interviewing sessions by patients who are randomized to the intervention (MI).

MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence

MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence

Condition
End Stage Renal Disease on Dialysis
Intervention / Treatment

-

Contacts and Locations

Philadelphia, PA 19123

Buttonwood DaVita Dialysis 449 N Broad St,, Philadelphia, PA 19123, Pennsylvania, United States, 19123

Philadelphia

DaVita Philadelphia PMC Dialysis, Philadelphia, Pennsylvania, United States, 19104

Philadelphia

DaVita University City Dialysis, Philadelphia, Pennsylvania, United States, 19104

Nashville

Vanderbilt Dialysis Clinic, Nashville, Tennessee, United States, 37204

Nashville

Dialysis Clinic, Inc., Nashville, Tennessee, United States, 37208

Nashville

Vanderbilt Dialysis Clinic East, Nashville, Tennessee, United States, 37214

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * African American
  • * Receiving hemodialysis treatments
  • * Been on hemodialysis for more than 30 days
  • * 18 years of age and older
  • * Within a 2-month look back at the time of screening, patients who have missed at least one dialysis session or shortened at least one dialysis session by 15 minutes.
  • * Not self-identified as African American
  • * Impaired with mental status or severe illness
  • * Non-English speaking
  • * No documented evidence of dialysis treatment non-adherence
  • * Missed or shortened treatments due to hospitalizations or excused travel
  • * Terminal condition
  • * Living in a nursing home/rehab
  • * Planned transplant within the next 6 months
  • * Planned conversion to peritoneal dialysis within the next 6 months

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Vanderbilt University Medical Center,

Ebele M Umeukeje, MD, MPH, PRINCIPAL_INVESTIGATOR, Vanderbilt University Medical Center

Study Record Dates

2027-11-01